MktsMarkets

Harvard Bioscience, Inc.
NASDAQ: HBIOKey statistics
HBIO News
Stories mentioning HBIO from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 20,755 | 23,735 | 20,591 | 20,450 | 21,774 | 24,556 | 21,970 | 23,097 |
| Cost of Goods Sold | 8,511 | 9,563 | 8,570 | 8,917 | 9,590 | 10,545 | 9,205 | 9,879 |
| Gross Profit | 12,244 | 14,172 | 12,021 | 11,533 | 12,184 | 14,011 | 12,765 | 13,218 |
| Operating Expenses | ||||||||
| Research & Development | 2,326 | 2,183 | 2,132 | 2,189 | 2,321 | 2,328 | 2,567 | 2,626 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 13,418 | 12,462 | 11,824 | 12,352 | 61,852 | 14,000 | 14,639 | 15,287 |
| Operating Income (Loss) | (1,174) | 1,710 | 197.00 | (819.00) | (49,668) | 11.00 | (1,874) | (2,069) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (405.00) | (1,454) | (365.00) | (644.00) | (193.00) | 516.00 | (518.00) | (181.00) |
| Pretax Income | (3,307) | (3,204) | (1,134) | (2,254) | (50,794) | 590.00 | (4,491) | (3,280) |
| Tax Provision | 117.00 | (357.00) | 97.00 | 28.00 | (454.00) | 572.00 | 311.00 | (353.00) |
| Net Income (Loss) | (3,424) | (2,847) | (1,231) | (2,282) | (50,340) | 18.00 | (4,802) | (2,927) |
| Earnings Per Share (Basic) | (0.77) | (0.06) | (0.03) | (0.05) | (11.42) | 0.00 | (0.11) | (0.07) |
| Earnings Per Share (Diluted) | (0.77) | (0.06) | (0.03) | (0.05) | (11.42) | 0.00 | (0.11) | (0.07) |
| Weighted Average Shares Outstanding (Basic) | 4,473 | 44,391 | 44,556 | 44,303 | 4,410 | 43,538 | 43,614 | 43,486 |
| Weighted Average Shares Outstanding (Diluted) | 4,473 | 44,391 | 44,556 | 44,303 | 4,410 | 43,538 | 43,614 | 43,486 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About HBIO
Harvard Bioscience, Inc. (NASDAQ: HBIO) is a stock listed on the Nasdaq Stock Market under the ticker symbol HBIO. It last traded at $9.08 (Nov 17, 2026, 4:00 PM ET), up 1.9% on the day. That gives Harvard Bioscience a market capitalisation of $42.1M.
Over the past 52 weeks HBIO has traded between $4.00 and $10.20.
Revenue for the quarter ended Mar 31, 2026 was $20.8M; a net loss of $3.4M. Revenue was down 4.7% from $21.8M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $20.8M | -$3.4M | -16.5% |
| Dec 31, 2025 | $23.7M | -$2.8M | -12.0% |
| Sep 30, 2025 | $20.6M | -$1.2M | -6.0% |
| Jun 30, 2025 | $20.5M | -$2.3M | -11.2% |
From Harvard Bioscience’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…